Quest Diagnostics recently unveiled a suite of advanced diagnostics and support services designed to broaden access to lab tests for transplants. Quest hopes to improve testing compliance among ...

Quest Diagnostics delivered a Q4 performance that exceeded Wall Street’s revenue and earnings expectations, prompting a positive market reaction. Management attributed this outcome to strong organic ...

Quest Diagnostics has outperformed the broader market over the past year, and analysts remain somewhat bullish about the stock’s prospects.

The Quest Diagnostics patient service center at 1 Randall Square reopened last week following renovations. Quest leaders ...

Quest Diagnostics may be the preferred lab your health insurance, doctors, or specialists use for blood work or other samples. We’re reviewing its sub-brand Quest Health, from which you can order your ...

Quest Diagnostics is a dominant player in the growing medical testing industry, offering consistent earnings and dividend growth with lower volatility. DGX benefits from secular tailwinds like aging ...

Analysts estimate that Quest Diagnostics will report an earnings per share (EPS) of $2.35. Anticipation surrounds Quest Diagnostics's announcement, with investors hoping to hear about both surpassing ...

Quest Diagnostics Incorporated (NYSE:DGX) Q4 2025 Earnings Call Transcript February 10, 2026 Quest Diagnostics Incorporated ...

Quest Diagnostics (NASDAQ:DGX) posted better-than-expected earnings for the third quarter on Tuesday. While Quest Diagnostics raised its revenue and adjusted earnings guidance for full-year 2025, the ...

In the last three months, 7 analysts have published ratings on Quest Diagnostics (NYSE:DGX), offering a diverse range of perspectives from bullish to bearish. In the table below, you'll find a summary ...

One of the top diagnostics specialists on the market published quarterly and full-year results. It not only scored a double beat on analyst projections, but its revenue guidance came out ahead as well ...

DGX tops Q4 EPS and revenue estimates as volumes rise, shares jump premarket, and 2026 guidance points to steady growth.